{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T14:24:35Z","timestamp":1742912675287,"version":"3.40.3"},"publisher-location":"Dordrecht","reference-count":117,"publisher":"Springer Netherlands","isbn-type":[{"type":"print","value":"9789400727731"},{"type":"electronic","value":"9789400727748"}],"license":[{"start":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T00:00:00Z","timestamp":1323302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T00:00:00Z","timestamp":1323302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-94-007-2774-8_13","type":"book-chapter","created":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T10:14:57Z","timestamp":1326190497000},"page":"407-432","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transthyretin Aggregation and Toxicity"],"prefix":"10.1007","author":[{"given":"Maria Jo\u00e3o","family":"Saraiva","sequence":"first","affiliation":[]},{"given":"Isabel Santos","family":"Cardoso","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,12,8]]},"reference":[{"key":"13_CR1_13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1042\/BJ20040011","volume":"381","author":"MR Almeida","year":"2004","unstructured":"Almeida MR, Macedo B, Cardoso I, Alves I, Valencia G, Arsequell G, Planas A, Saraiva MJ (2004) Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative. Biochem J 381:351\u2013356","journal-title":"Biochem J"},{"key":"13_CR2_13","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2174\/156800705774322076","volume":"4","author":"MR Almeida","year":"2005","unstructured":"Almeida MR, Gales L, Damas AM, Cardoso I, Saraiva MJ (2005) Small transthyretin (TTR) ligands as possible therapeutic agents in TTR amyloidoses. Curr Drug Targets CNS Neurol Disord 4:587\u2013596","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"13_CR3_13","first-page":"51","volume":"17","author":"R Alvarez","year":"2010","unstructured":"Alvarez R, Borland T, Chen Q, Milstein S, Nguyen T, Hinkle G, Kuchimanchi S, Costigan J, Ristoiu V, Wang G, Cole G, Dorkin R, Akinc A, Nechev L, Kosovrasti V, Tchangov L, Tracy M, Jeffs L, Maclachlan I, Lutwyche P, Martins D, Costelha S, Saraiva MJ, Sah DWY (2010) ALN-TTR, an RNAi therapeutic for the treatment of transthyretin-mediated amyloidosis. Amyloid J Protein Fold Disord 17:51\u201352","journal-title":"Amyloid J Protein Fold Disord"},{"key":"13_CR4_13","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/(SICI)1098-1004(1997)9:3<226::AID-HUMU3>3.0.CO;2-5","volume":"9","author":"IL Alves","year":"1997","unstructured":"Alves IL, Altland K, Almeida MR, Winter P, Saraiva MJ (1997) Screening and biochemical characterization of transthyretin variants in the Portuguese population. Hum Mutat 9:226\u2013233","journal-title":"Hum Mutat"},{"key":"13_CR5_13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.0954-6820.1970.tb08009.x","volume":"1\u20132","author":"R Andersson","year":"1970","unstructured":"Andersson R (1970) Hereditary amyloidosis with polyneuropathy. Acta Med Scand 1\u20132:85\u201394","journal-title":"Acta Med Scand"},{"key":"13_CR6_13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0006-291X(02)00465-5","volume":"294","author":"K Andersson","year":"2002","unstructured":"Andersson K, Olofsson A, Nielsen EH, Svehag SE, Lundgren E (2002) Only amyloidogenic intermediates of transthyretin induce apoptosis. Biochem Biophys Res Commun 294:309\u2013314","journal-title":"Biochem Biophys Res Commun"},{"key":"13_CR7_13","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/brain\/75.3.408","volume":"75","author":"C Andrade","year":"1952","unstructured":"Andrade C (1952) A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 75:408\u2013427","journal-title":"Brain"},{"key":"13_CR8_13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0002-9343(01)00774-4","volume":"111","author":"E Anesi","year":"2001","unstructured":"Anesi E, Palladini G, Perfetti V, Arbustini E, Obici L, Merlini G (2001) Therapeutic advances demand accurate typing of amyloid deposits. Am J Med 111:243\u2013244","journal-title":"Am J Med"},{"key":"13_CR9_13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0387-7604(84)80061-3","volume":"6","author":"S Araki","year":"1984","unstructured":"Araki S (1984) Type I familial amyloidotic polyneuropathy (Japanese type). Brain Dev 6:128\u2013133","journal-title":"Brain Dev"},{"key":"13_CR10_13","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/0022-2836(81)90125-X","volume":"152","author":"PJ Artymiuk","year":"1981","unstructured":"Artymiuk PJ, Blake CC (1981) Refinement of human lysozyme at 1.5 \u00c5 resolution analysis of non-bonded and hydrogen-bond interactions. J Mol Biol 152:737\u2013762","journal-title":"J Mol Biol"},{"key":"13_CR11_13","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0968-0896(98)00130-8","volume":"6","author":"PW Baures","year":"1998","unstructured":"Baures PW, Peterson SA, Kelly JW (1998) Discovering transthyretin amyloid fibril inhibitors by limited screening. Bioorg Med Chem 6:1389\u20131401","journal-title":"Bioorg Med Chem"},{"key":"13_CR12_13","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/S0968-0896(99)00066-8","volume":"7","author":"PW Baures","year":"1999","unstructured":"Baures PW, Oza VB, Peterson SA, Kelly JW (1999) Synthesis and evaluation of inhibitors of transthyretin amyloid formation based on the non-steroidal anti-inflammatory drug, flufenamic acid. Bioorg Med Chem 7:1339\u20131347","journal-title":"Bioorg Med Chem"},{"key":"13_CR13_13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/mus.20821","volume":"36","author":"MD Benson","year":"2007","unstructured":"Benson MD, Kincaid JC (2007) The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 36:411\u2013423","journal-title":"Muscle Nerve"},{"key":"13_CR14_13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000213761","volume":"6","author":"I Berg","year":"2009","unstructured":"Berg I, Thor S, Hammarstrom P (2009) Modeling familial amyloidotic polyneuropathy (transthyretin V30M) in Drosophila melanogaster. Neurodegener Dis 6:127\u2013138","journal-title":"Neurodegener Dis"},{"key":"13_CR15_13","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0022-2836(78)90368-6","volume":"121","author":"CC Blake","year":"1978","unstructured":"Blake CC, Geisow MJ, Oatley SJ, Rerat B, Rerat C (1978) Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 \u00c5. J Mol Biol 121:339\u2013356","journal-title":"J Mol Biol"},{"key":"13_CR16_13","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1073\/pnas.0712197105","volume":"105","author":"JN Buxbaum","year":"2008","unstructured":"Buxbaum JN, Ye Z, Reixach N, Friske L, Levy C, Das P, Golde T, Masliah E, Roberts AR, Bartfai T (2008) Transthyretin protects Alzheimer\u2019s mice from the behavioral and biochemical effects of A\u03b2 toxicity. Proc Natl Acad Sci USA 105:2681\u20132686","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR17_13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1096\/fj.05-4509com","volume":"20","author":"I Cardoso","year":"2006","unstructured":"Cardoso I, Saraiva MJ (2006) Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model. FASEB J 20:234\u2013239","journal-title":"FASEB J"},{"key":"13_CR18_13","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1006\/jmbi.2002.5441","volume":"317","author":"I Cardoso","year":"2002","unstructured":"Cardoso I, Goldsbury CS, Muller SA, Olivieri V, Wirtz S, Damas AM, Aebi U, Saraiva MJ (2002) Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils. J Mol Biol 317:683\u2013695","journal-title":"J Mol Biol"},{"key":"13_CR19_13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1096\/fj.02-0764com","volume":"17","author":"I Cardoso","year":"2003","unstructured":"Cardoso I, Merlini G, Saraiva MJ (2003) 4\u2019-Iodo-4\u2019-deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species: screening for TTR fibril disrupters. FASEB J 17:803\u2013809","journal-title":"FASEB J"},{"key":"13_CR20_13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1042\/BJ20070689","volume":"408","author":"I Cardoso","year":"2007","unstructured":"Cardoso I, Almeida MR, Ferreira N, Arsequell G, Valencia G, Saraiva MJ (2007) Comparative in vitro and ex vivo activities of selected inhibitors of transthyretin aggregation: relevance in drug design. Biochem J 408:131\u2013138","journal-title":"Biochem J"},{"key":"13_CR21_13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1155\/2008\/549872","volume":"25","author":"I Cardoso","year":"2008","unstructured":"Cardoso I, Brito M, Saraiva MJ (2008) Extracellular matrix markers for disease progression and follow-up of therapies in familial amyloid polyneuropathy V30M TTR-related. Dis Markers 25:37\u201347","journal-title":"Dis Markers"},{"key":"13_CR22_13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1479-5876-8-74","volume":"8","author":"I Cardoso","year":"2010","unstructured":"Cardoso I, Martins D, Ribeiro T, Merlini G, Saraiva MJ (2010) Synergy of combined doxycycline\/TUDCA treatment in lowering transthyretin deposition and associated biomarkers: studies in FAP mouse models. J Transl Med 8:74","journal-title":"J Transl Med"},{"key":"13_CR23_13","doi-asserted-by":"publisher","first-page":"7006","DOI":"10.1523\/JNEUROSCI.1919-07.2007","volume":"27","author":"SH Choi","year":"2007","unstructured":"Choi SH, Leight SN, Lee VM, Li T, Wong PC, Johnson JA, Saraiva MJ, Sisodia SS (2007) Accelerated A\u03b2 deposition in APPswe\/PS1\u0394E9 mice with hemizygous deletions of TTR \u00ad(transthyretin). J Neurosci 27:7006\u20137010","journal-title":"J Neurosci"},{"key":"13_CR24_13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3109\/13506129.2010.483119","volume":"17","author":"T Coelho","year":"2010","unstructured":"Coelho T, Maia L, Da Silva AM, Waddingtion-Cruz M, Plante-Bordeneuve V, Lozeron P, Suhr OB, Campistol J, Conceicao IM, Schmidt H, Trigo P, Packman J, Grogan DR (2010) Tafamidis (Fx-1006A): a first-in-class disease-modifying therapy for transthyretin familial amyloid. Amyloid-J Protein Fold Disord 17:75\u201376","journal-title":"Amyloid-J Protein Fold Disord"},{"key":"13_CR25_13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/brain\/94.2.199","volume":"94","author":"A Coimbra","year":"1971","unstructured":"Coimbra A, Andrade C (1971a) Familial amyloid polyneuropathy: an electron microscope study of the peripheral nerve in five cases. I. Interstitial changes. Brain 94:199\u2013206","journal-title":"Brain"},{"key":"13_CR26_13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/brain\/94.2.207","volume":"94","author":"A Coimbra","year":"1971","unstructured":"Coimbra A, Andrade C (1971b) Familial amyloid polyneuropathy: an electron microscope study of the peripheral nerve in five cases. II. Nerve fibre changes. Brain 94:207\u2013212","journal-title":"Brain"},{"key":"13_CR27_13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.sbi.2009.12.009","volume":"20","author":"S Connelly","year":"2010","unstructured":"Connelly S, Choi S, Johnson SM, Kelly JW, Wilson IA (2010) Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses. Curr Opin Struct Biol 20:54\u201362","journal-title":"Curr Opin Struct Biol"},{"key":"13_CR28_13","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/0006-291X(88)90188-X","volume":"154","author":"GG Cornwell 3rd","year":"1988","unstructured":"Cornwell GG 3rd, Sletten K, Johansson B, Westermark P (1988) Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealbumin. Biochem Biophys Res Commun 154:648\u2013653","journal-title":"Biochem Biophys Res Commun"},{"key":"13_CR29_13","doi-asserted-by":"publisher","first-page":"e2899","DOI":"10.1371\/journal.pone.0002899","volume":"3","author":"R Costa","year":"2008","unstructured":"Costa R, Ferreira-Da-Silva F, Saraiva MJ, Cardoso I (2008) Transthyretin protects against A\u03b2 peptide toxicity by proteolytic cleavage of the peptide: a mechanism sensitive to the Kunitz protease inhibitor. PLoS One 3:e2899","journal-title":"PLoS One"},{"key":"13_CR30_13","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1107\/S0907444996003307","volume":"52","author":"AM Damas","year":"1996","unstructured":"Damas AM, Ribeiro S, Lamzin VS, Palha JA, Saraiva MJ (1996) Structure of the Val122Ile variant transthyretin\u2014a cardiomyopathic mutant. Acta Crystallogr D Biol Crystallogr 52:966\u2013972","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"13_CR31_13","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/archneur.1969.00480110054005","volume":"20","author":"PJ Dyck","year":"1969","unstructured":"Dyck PJ, Lambert EH (1969) Dissociated sensation in amyloidosis. Compound action potential, quantitative histologic and teased-fiber, and electron microscopic studies of sural nerve biopsies. Arch Neurol 20:490\u2013507","journal-title":"Arch Neurol"},{"key":"13_CR32_13","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/S1097-2765(00)00117-9","volume":"6","author":"T Eneqvist","year":"2000","unstructured":"Eneqvist T, Andersson K, Olofsson A, Lundgren E, Sauer-Eriksson AE (2000) The \u03b2-slip: a novel concept in transthyretin amyloidosis. Mol Cell 6:1207\u20131218","journal-title":"Mol Cell"},{"key":"13_CR33_13","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1073\/pnas.90.6.2375","volume":"90","author":"V Episkopou","year":"1993","unstructured":"Episkopou V, Maeda S, Nishiguchi S, Shimada K, Gaitanaris GA, Gottesman ME, Robertson EJ (1993) Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proc Natl Acad Sci USA 90:2375\u20132379","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR34_13","doi-asserted-by":"publisher","first-page":"6445","DOI":"10.1073\/pnas.97.12.6445","volume":"97","author":"AD Ferr\u00e3o-Gon\u00e7alves","year":"2000","unstructured":"Ferr\u00e3o-Gon\u00e7alves AD, Souto SO, Silva JL, Foguel D (2000) The preaggregated state of an amyloidogenic protein: hydrostatic pressure converts native transthyretin into the amyloidogenic state. Proc Natl Acad Sci USA 97:6445\u20136450","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR35_13","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1016\/j.febslet.2009.10.062","volume":"583","author":"N Ferreira","year":"2009","unstructured":"Ferreira N, Cardoso I, Domingues MR, Vitorino R, Bastos M, Bai G, Saraiva MJ, Almeida MR (2009) Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity. FEBS Lett 583:3569\u20133576","journal-title":"FEBS Lett"},{"key":"13_CR36_13","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1471-4159.2007.04828.x","volume":"103","author":"CE Fleming","year":"2007","unstructured":"Fleming CE, Saraiva MJ, Sousa MM (2007) Transthyretin enhances nerve regeneration. J Neurochem 103:831\u2013839","journal-title":"J Neurochem"},{"key":"13_CR37_13","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1021\/bi961649c","volume":"36","author":"G Goldsteins","year":"1997","unstructured":"Goldsteins G, Andersson K, Olofsson A, Dacklin I, Edvinsson A, Baranov V, Sandgren O, Thylen C, Hammarstrom S, Lundgren E (1997) Characterization of two highly amyloidogenic mutants of transthyretin. Biochemistry 36:5346\u20135352","journal-title":"Biochemistry"},{"key":"13_CR38_13","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1172\/JCI113966","volume":"83","author":"PD Gorevic","year":"1989","unstructured":"Gorevic PD, Prelli FC, Wright J, Pras M, Frangione B (1989) Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy. J Clin Invest 83:836\u2013843","journal-title":"J Clin Invest"},{"key":"13_CR39_13","volume-title":"Amyloid and amyloidosis","author":"A Guimar\u00e3es","year":"1988","unstructured":"Guimar\u00e3es A, Viana Pinheiro A, Leite I (1988) Sural nerve biopsy in familial amyloidotic \u00adpolyneuropathy: a morphological and morphometric polyneuropathy. In: Isobe T, Araki S, Uchino F, Kito S, Tsubura E (eds) Amyloid and amyloidosis. Plenum Press, New York"},{"key":"13_CR40_13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/13506129609014349","volume":"3","author":"JA Hamilton","year":"1996","unstructured":"Hamilton JA, Steinrauf LK, Braden BC, Murrell JR, Benson MD (1996) Structural changes in transthyretin produced by the Ile84Ser mutation which result in decreased affinity for retinol binding protein. Amyloid-Int J Exp Clin Investig 3:1\u201312","journal-title":"Amyloid-Int J Exp Clin Investig"},{"key":"13_CR41_13","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1126\/science.1062245","volume":"293","author":"P Hammarstr\u00f6m","year":"2001","unstructured":"Hammarstr\u00f6m P, Schneider F, Kelly JW (2001) Trans-suppression of misfolding in an amyloid disease. Science 293:2459\u20132462","journal-title":"Science"},{"key":"13_CR42_13","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1021\/bi027319b","volume":"42","author":"P Hammarstr\u00f6m","year":"2003","unstructured":"Hammarstr\u00f6m P, Sekijima Y, White JT, Wiseman RL, Lim A, Costello CE, Altland K, Garzuly F, Budka H, Kelly JW (2003a) D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis? Biochemistry 42:6656\u20136663","journal-title":"Biochemistry"},{"key":"13_CR43_13","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1126\/science.1079589","volume":"299","author":"P Hammarstr\u00f6m","year":"2003","unstructured":"Hammarstr\u00f6m P, Wiseman RL, Powers ET, Kelly JW (2003b) Prevention of transthyretin amyloid disease by changing protein misfolding energetics. Science 299:713\u2013716","journal-title":"Science"},{"key":"13_CR44_13","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/j.1432-1033.1995.tb20200.x","volume":"227","author":"LF Hermansen","year":"1995","unstructured":"Hermansen LF, Bergman T, Jornvall H, Husby G, Ranlov I, Sletten K (1995) Purification and characterization of amyloid-related transthyretin associated with familial amyloidotic cardiomyopathy. Eur J Biochem 227:772\u2013779","journal-title":"Eur J Biochem"},{"key":"13_CR45_13","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1006\/jmbi.2000.4078","volume":"302","author":"A H\u00f6rnberg","year":"2000","unstructured":"H\u00f6rnberg A, Eneqvist T, Olofsson A, Lundgren E, Sauer-Eriksson AE (2000) A comparative analysis of 23 structures of the amyloidogenic protein transthyretin. J Mol Biol 302:649\u2013669","journal-title":"J Mol Biol"},{"key":"13_CR46_13","doi-asserted-by":"publisher","first-page":"11618","DOI":"10.1021\/bi050700m","volume":"44","author":"X Hou","year":"2005","unstructured":"Hou X, Richardson SJ, Aguilar MI, Small DH (2005) Binding of amyloidogenic transthyretin to the plasma membrane alters membrane fluidity and induces neurotoxicity. Biochemistry 44:11618\u201311627","journal-title":"Biochemistry"},{"key":"13_CR47_13","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1111\/j.1742-4658.2007.05712.x","volume":"274","author":"X Hou","year":"2007","unstructured":"Hou X, Aguilar MI, Small DH (2007) Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration. FEBS J 274:1637\u20131650","journal-title":"FEBS J"},{"key":"13_CR48_13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/jsbi.1998.4052","volume":"124","author":"S Inoue","year":"1998","unstructured":"Inoue S, Kuroiwa M, Saraiva MJ, Guimaraes A, Kisilevsky R (1998) Ultrastructure of familial amyloid polyneuropathy amyloid fibrils: examination with high-resolution electron microscopy. J Struct Biol 124:1\u201312","journal-title":"J Struct Biol"},{"key":"13_CR49_13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3109\/13506129809003842","volume":"5","author":"H Inouye","year":"1998","unstructured":"Inouye H, Domingues FS, Damas AM, Saraiva MJ, Lundgren E, Sandgren O, Kirschner DA (1998) Analysis of X-ray diffraction patterns from amyloid of biopsied vitreous humor and kidney of transthyretin (TTR) Met30 familial amyloidotic polyneuropathy (FAP) patients: \u00adaxially arrayed TTR monomers constitute the protofilament. Amyloid 5:163\u2013174","journal-title":"Amyloid"},{"key":"13_CR50_13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/BF00220559","volume":"89","author":"DR Jacobson","year":"1992","unstructured":"Jacobson DR, Mcfarlin DE, Kane I, Buxbaum JN (1992) Transthyretin Pro55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvement. Hum Genet 89:353\u2013356","journal-title":"Hum Genet"},{"key":"13_CR51_13","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1056\/NEJM199702133360703","volume":"336","author":"DR Jacobson","year":"1997","unstructured":"Jacobson DR, Pastore RD, Yaghoubian R, Kane I, Gallo G, Buck FS, Buxbaum JN (1997) Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med 336:466\u2013473","journal-title":"N Engl J Med"},{"key":"13_CR52_13","doi-asserted-by":"publisher","first-page":"24985","DOI":"10.1074\/jbc.M100252200","volume":"276","author":"A Kakio","year":"2001","unstructured":"Kakio A, Nishimoto SI, Yanagisawa K, Kozutsumi Y, Matsuzaki K (2001) Cholesterol-dependent formation of GM1 ganglioside-bound amyloid \u03b2-protein, an endogenous seed for Alzheimer amyloid. J Biol Chem 276:24985\u201324990","journal-title":"J Biol Chem"},{"key":"13_CR53_13","doi-asserted-by":"crossref","first-page":"6796","DOI":"10.1016\/S0021-9258(19)42128-5","volume":"249","author":"Y Kanda","year":"1974","unstructured":"Kanda Y, Goodman DS, Canfield RE, Morgan FJ (1974) The amino acid sequence of human plasma prealbumin. J Biol Chem 249:6796\u20136805","journal-title":"J Biol Chem"},{"key":"13_CR54_13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed R, Head E, Thompson JL, Mcintire TM, Milton SC, Cotman CW, Glabe CG (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486\u2013489","journal-title":"Science"},{"key":"13_CR55_13","doi-asserted-by":"publisher","first-page":"10671","DOI":"10.1073\/pnas.162362299","volume":"99","author":"CD Keene","year":"2002","unstructured":"Keene CD, Rodrigues CM, Eich T, Chhabra MS, Steer CJ, Low WC (2002) Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington\u2019s disease. Proc Natl Acad Sci USA 99:10671\u201310676","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR56_13","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/74082","volume":"7","author":"T Klabunde","year":"2000","unstructured":"Klabunde T, Petrassi HM, Oza VB, Raman P, Kelly JW, Sacchettini JC (2000) Rational design of potent human transthyretin amyloid disease inhibitors. Nat Struct Biol 7:312\u2013321","journal-title":"Nat Struct Biol"},{"key":"13_CR57_13","first-page":"1497","volume":"150","author":"K Kohno","year":"1997","unstructured":"Kohno K, Palha JA, Miyakawa K, Saraiva MJ, Ito S, Mabuchi T, Blaner WS, Iijima H, Tsukahara S, Episkopou V, Gottesman ME, Shimada K, Takahashi K, Yamamura K, Maeda S (1997) Analysis of amyloid deposition in a transgenic mouse model of homozygous familial \u00adamyloidotic polyneuropathy. Am J Pathol 150:1497\u20131508","journal-title":"Am J Pathol"},{"key":"13_CR58_13","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1111\/j.1742-4658.2010.07571.x","volume":"277","author":"M Lindgren","year":"2010","unstructured":"Lindgren M, Hammarstr\u00f6m P (2010) Amyloid oligomers: spectroscopic characterization of amyloidogenic protein states. FEBS J 277:1380\u20131388","journal-title":"FEBS J"},{"key":"13_CR59_13","doi-asserted-by":"publisher","first-page":"21431","DOI":"10.1074\/jbc.M402212200","volume":"279","author":"MA Liz","year":"2004","unstructured":"Liz MA, Faro CJ, Saraiva MJ, Sousa MM (2004) Transthyretin, a new cryptic protease. J Biol Chem 279:21431\u201321438","journal-title":"J Biol Chem"},{"key":"13_CR60_13","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1432-1033.1997.00662.x","volume":"249","author":"I Longo Alves","year":"1997","unstructured":"Longo Alves I, Hays MT, Saraiva MJ (1997) Comparative stability and clearance of [Met30]transthyretin and [Met119]transthyretin. Eur J Biochem 249:662\u2013668","journal-title":"Eur J Biochem"},{"key":"13_CR61_13","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bbadis.2008.05.005","volume":"1782","author":"B Macedo","year":"2008","unstructured":"Macedo B, Batista AR, Ferreira N, Almeida MR, Saraiva MJ (2008) Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of familial amyloidotic polyneuropathy. Biochim Biophys Acta 1782:517\u2013522","journal-title":"Biochim Biophys Acta"},{"key":"13_CR62_13","doi-asserted-by":"publisher","first-page":"12119","DOI":"10.1021\/bi00096a024","volume":"32","author":"SL Mccutchen","year":"1993","unstructured":"Mccutchen SL, Colon W, Kelly JW (1993) Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity. Biochemistry 32:12119\u201312127","journal-title":"Biochemistry"},{"key":"13_CR63_13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1471-4159.2006.03716.x","volume":"97","author":"FA Monteiro","year":"2006","unstructured":"Monteiro FA, Sousa MM, Cardoso I, Do Amaral JB, Guimaraes A, Saraiva MJ (2006) Activation of ERK1\/2 MAP kinases in familial amyloidotic polyneuropathy. J Neurochem 97:151\u2013161","journal-title":"J Neurochem"},{"key":"13_CR64_13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3109\/13506129709014383","volume":"4","author":"M Munarqu\u00e9s","year":"1997","unstructured":"Munarqu\u00e9s M, Costa PP, Saraiva MJM, Viaderfarr\u00e9 C, Munarbernat C, Cifuentesluna C, Fortezaalberti JF (1997) Familial amyloidotic polyneuropathy. TTR Met30 in Majorca (Spain). Amyloid Int J Exp Clin Investig 4:181\u2013186","journal-title":"Amyloid Int J Exp Clin Investig"},{"key":"13_CR65_13","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.bbapap.2010.03.010","volume":"1804","author":"T Nakanishi","year":"2010","unstructured":"Nakanishi T, Yoshioka M, Moriuchi K, Yamamoto D, Tsuji M, Takubo T (2010) S-sulfonation of transthyretin is an important trigger step in the formation of transthyretin-related amyloid fibril. Biochim Biophys Acta 1804:1449\u20131456","journal-title":"Biochim Biophys Acta"},{"key":"13_CR66_13","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0006-291X(84)80222-3","volume":"123","author":"M Nakazato","year":"1984","unstructured":"Nakazato M, Kangawa K, Minamino N, Tawara S, Matsuo H, Araki S (1984) Revised analysis of amino acid replacement in a prealbumin variant (SKO-III) associated with familial amyloidotic polyneuropathy of Jewish origin. Biochem Biophys Res Commun 123:921\u2013928","journal-title":"Biochem Biophys Res Commun"},{"key":"13_CR67_13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1096\/fj.05-4106fje","volume":"20","author":"AF Nunes","year":"2006","unstructured":"Nunes AF, Saraiva MJ, Sousa MM (2006) Transthyretin knockouts are a new mouse model for increased neuropeptide Y. FASEB J 20:166\u2013168","journal-title":"FASEB J"},{"key":"13_CR68_13","doi-asserted-by":"publisher","first-page":"39592","DOI":"10.1074\/jbc.M103599200","volume":"276","author":"A Olofsson","year":"2001","unstructured":"Olofsson A, Ippel HJ, Baranov V, Horstedt P, Wijmenga S, Lundgren E (2001) Capture of a dimeric intermediate during transthyretin amyloid formation. J Biol Chem 276:39592\u201339599","journal-title":"J Biol Chem"},{"key":"13_CR69_13","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.1074\/jbc.M310605200","volume":"279","author":"A Olofsson","year":"2004","unstructured":"Olofsson A, Ippel JH, Wijmenga SS, Lundgren E, Ohman A (2004) Probing solvent accessibility of transthyretin amyloid by solution NMR spectroscopy. J Biol Chem 279:5699\u20135707","journal-title":"J Biol Chem"},{"key":"13_CR70_13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0960-894X(98)00696-9","volume":"9","author":"VB Oza","year":"1999","unstructured":"Oza VB, Petrassi HM, Purkey HE, Kelly JW (1999) Synthesis and evaluation of anthranilic acid-based transthyretin amyloid fibril inhibitors. Bioorg Med Chem Lett 9:1\u20136","journal-title":"Bioorg Med Chem Lett"},{"key":"13_CR71_13","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/j.1460-9568.2007.05728.x","volume":"26","author":"M Pokrzywa","year":"2007","unstructured":"Pokrzywa M, Dacklin I, Hultmark D, Lundgren E (2007) Misfolded transthyretin causes behavioral changes in a Drosophila model for transthyretin-associated amyloidosis. Eur J Neurosci 26:913\u2013924","journal-title":"Eur J Neurosci"},{"key":"13_CR72_13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0014-5793(97)01398-7","volume":"418","author":"A Quintas","year":"1997","unstructured":"Quintas A, Saraiva MJ, Brito RM (1997) The amyloidogenic potential of transthyretin variants correlates with their tendency to aggregate in solution. FEBS Lett 418:297\u2013300","journal-title":"FEBS Lett"},{"key":"13_CR73_13","doi-asserted-by":"publisher","first-page":"32943","DOI":"10.1074\/jbc.274.46.32943","volume":"274","author":"A Quintas","year":"1999","unstructured":"Quintas A, Saraiva MJ, Brito RM (1999) The tetrameric protein transthyretin dissociates to a \u00adnon-native monomer in solution. A novel model for amyloidogenesis. J Biol Chem 274:32943\u201332949","journal-title":"J Biol Chem"},{"key":"13_CR74_13","doi-asserted-by":"publisher","first-page":"27207","DOI":"10.1074\/jbc.M101024200","volume":"276","author":"A Quintas","year":"2001","unstructured":"Quintas A, Vaz DC, Cardoso I, Saraiva MJ, Brito RM (2001) Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants. J Biol Chem 276:27207\u201327213","journal-title":"J Biol Chem"},{"key":"13_CR75_13","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1016\/S0021-9258(18)93118-2","volume":"244","author":"A Raz","year":"1969","unstructured":"Raz A, Goodman DS (1969) The interaction of thyroxine with human plasma prealbumin and with the prealbumin-retinol-binding protein complex. J Biol Chem 244:3230\u20133237","journal-title":"J Biol Chem"},{"key":"13_CR76_13","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1006\/jmbi.2000.4220","volume":"304","author":"C Redondo","year":"2000","unstructured":"Redondo C, Damas AM, Olofsson A, Lundgren E, Saraiva MJ (2000a) Search for intermediate structures in transthyretin fibrillogenesis: soluble tetrameric Tyr78Phe TTR expresses a specific epitope present only in amyloid fibrils. J Mol Biol 304:461\u2013470","journal-title":"J Mol Biol"},{"issue":"Pt 1","key":"13_CR77_13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1042\/0264-6021:3480167","volume":"348","author":"C Redondo","year":"2000","unstructured":"Redondo C, Damas AM, Saraiva MJ (2000b) Designing transthyretin mutants affecting tetrameric structure: implications in amyloidogenicity. Biochem J 348(Pt 1):167\u2013172","journal-title":"Biochem J"},{"key":"13_CR78_13","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1073\/pnas.0400062101","volume":"101","author":"N Reixach","year":"2004","unstructured":"Reixach N, Deechongkit S, Jiang X, Kelly JW, Buxbaum JN (2004) Tissue damage in the amyloidoses: transthyretin monomers and nonnative oligomers are the major cytotoxic species in \u00adtissue culture. Proc Natl Acad Sci USA 101:2817\u20132822","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR79_13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/pro.289","volume":"19","author":"JR Rodrigues","year":"2010","unstructured":"Rodrigues JR, Simoes CJ, Silva CG, Brito RM (2010) Potentially amyloidogenic conformational intermediates populate the unfolding landscape of transthyretin: insights from molecular dynamics simulations. Protein Sci 19:202\u2013219","journal-title":"Protein Sci"},{"key":"13_CR80_13","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1212\/WNL.34.8.1025","volume":"34","author":"G Said","year":"1984","unstructured":"Said G, Ropert A, Faux N (1984) Length-dependent degeneration of fibers in Portuguese amyloid polyneuropathy: a clinicopathologic study. Neurology 34:1025\u20131032","journal-title":"Neurology"},{"key":"13_CR81_13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1472-6807-5-18","volume":"5","author":"N S\u00e1nchez De Groot","year":"2005","unstructured":"S\u00e1nchez De Groot N, Pallar\u00e9s I, Avil\u00e9s FX, Vendrell J, Ventura S (2005) Prediction of \u201chot spots\u201d of aggregation in disease-linked polypeptides. BMC Struct Biol 5:18","journal-title":"BMC Struct Biol"},{"key":"13_CR82_13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/path.2224","volume":"213","author":"SD Santos","year":"2007","unstructured":"Santos SD, Cardoso I, Magalhaes J, Saraiva MJ (2007) Impairment of the ubiquitin-proteasome system associated with extracellular transthyretin aggregates in familial amyloidotic polyneuropathy. J Pathol 213:200\u2013209","journal-title":"J Pathol"},{"key":"13_CR83_13","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1016\/j.febslet.2008.07.025","volume":"582","author":"SD Santos","year":"2008","unstructured":"Santos SD, Costa R, Teixeira PF, Gottesman M, Cardoso I, Saraiva MJ (2008) Amyloidogenic properties of transthyretin-like protein (TLP) from Escherichia coli. FEBS Lett 582:2893\u20132898","journal-title":"FEBS Lett"},{"key":"13_CR84_13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.neurobiolaging.2008.04.001","volume":"31","author":"SD Santos","year":"2010","unstructured":"Santos SD, Fernandes R, Saraiva MJ (2010a) The heat shock response modulates transthyretin deposition in the peripheral and autonomic nervous systems. Neurobiol Aging 31:280\u2013289","journal-title":"Neurobiol Aging"},{"key":"13_CR85_13","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1111\/j.1471-4159.2010.07047.x","volume":"115","author":"SD Santos","year":"2010","unstructured":"Santos SD, Lambertsen KL, Clausen BH, Akinc A, Alvarez R, Finsen B, Saraiva MJ (2010b) CSF transthyretin neuroprotection in a mouse model of brain ischemia. J Neurochem 115:1434\u20131444","journal-title":"J Neurochem"},{"key":"13_CR86_13","volume-title":"Amyloid and amyloidosis 1990","author":"MJM Saraiva","year":"1991","unstructured":"Saraiva MJM, Costa PP (1991) Molecular biology of the amyloidogenesis in the transthyretin related amyloidoses. In: Natvig JB, F\u00f8rre \u00d8, Husby G, Husebekk A (eds) Amyloid and amyloidosis 1990. Kluwer Academic Publishers, Dordrecht"},{"key":"13_CR87_13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1172\/JCI111390","volume":"74","author":"MJ Saraiva","year":"1984","unstructured":"Saraiva MJ, Birken S, Costa PP, Goodman DS (1984) Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). J Clin Invest 74:104\u2013119","journal-title":"J Clin Invest"},{"key":"13_CR88_13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0378-1119(85)90272-0","volume":"37","author":"H Sasaki","year":"1985","unstructured":"Sasaki H, Yoshioka N, Takagi Y, Sakaki Y (1985) Structure of the chromosomal gene for human serum prealbumin. Gene 37:191\u2013197","journal-title":"Gene"},{"key":"13_CR89_13","doi-asserted-by":"publisher","first-page":"24715","DOI":"10.1074\/jbc.273.38.24715","volume":"273","author":"MP Sebasti\u00e3o","year":"1998","unstructured":"Sebasti\u00e3o MP, Saraiva MJ, Damas AM (1998) The crystal structure of amyloidogenic Leu55 \u2009\u2192 \u2009Pro transthyretin variant reveals a possible pathway for transthyretin polymerization into amyloid fibrils. J Biol Chem 273:24715\u201324722","journal-title":"J Biol Chem"},{"key":"13_CR90_13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1042\/0264-6021:3510273","volume":"351","author":"MP Sebasti\u00e3o","year":"2000","unstructured":"Sebasti\u00e3o MP, Merlini G, Saraiva MJ, Damas AM (2000) The molecular interaction of 4\u2019-iodo-4\u2019-deoxydoxorubicin with Leu-55Pro transthyretin \u2018amyloid-like\u2019 oligomer leading to disaggregation. Biochem J 351:273\u2013279","journal-title":"Biochem J"},{"key":"13_CR91_13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1006\/jmbi.2000.4415","volume":"306","author":"MP Sebasti\u00e3o","year":"2001","unstructured":"Sebasti\u00e3o MP, Lamzin V, Saraiva MJ, Damas AM (2001) Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolution. J Mol Biol 306:733\u2013744","journal-title":"J Mol Biol"},{"key":"13_CR92_13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cell.2005.01.018","volume":"121","author":"Y Sekijima","year":"2005","unstructured":"Sekijima Y, Wiseman RL, Matteson J, Hammarstrom P, Miller SR, Sawkar AR, Balch WE, Kelly JW (2005) The biological and chemical basis for tissue-selective amyloid disease. Cell 121:73\u201385","journal-title":"Cell"},{"key":"13_CR93_13","doi-asserted-by":"publisher","first-page":"9089","DOI":"10.1021\/bi010655s","volume":"40","author":"AA Serag","year":"2001","unstructured":"Serag AA, Altenbach C, Gingery M, Hubbell WL, Yeates TO (2001) Identification of a subunit interface in transthyretin amyloid fibrils: evidence for self-assembly from oligomeric building blocks. Biochemistry 40:9089\u20139096","journal-title":"Biochemistry"},{"issue":"Pt 4","key":"13_CR94_13","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/brain\/113.4.903","volume":"113","author":"G Sobue","year":"1990","unstructured":"Sobue G, Nakao N, Murakami K, Yasuda T, Sahashi K, Mitsuma T, Sasaki H, Sakaki Y, Takahashi A (1990) Type I familial amyloid polyneuropathy. A pathological study of the peripheral nervous system. Brain 113(Pt 4):903\u2013919","journal-title":"Brain"},{"key":"13_CR95_13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/bip.20705","volume":"86","author":"J S\u00f8rensen","year":"2007","unstructured":"S\u00f8rensen J, Hamelberg D, Schi\u00f8tt B, Mccammon JA (2007) Comparative MD analysis of the stability of transthyretin providing insight into the fibrillation mechanism. Biopolymers 86:73\u201382","journal-title":"Biopolymers"},{"key":"13_CR96_13","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jmb.2005.11.051","volume":"356","author":"K Sorgjerd","year":"2006","unstructured":"Sorgjerd K, Ghafouri B, Jonsson BH, Kelly JW, Blond SY, Hammarstr\u00f6m P (2006) Retention of misfolded mutant transthyretin by the chaperone BiP\/GRP78 mitigates amyloidogenesis. J Mol Biol 356:469\u2013482","journal-title":"J Mol Biol"},{"key":"13_CR97_13","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.bbrc.2008.10.121","volume":"377","author":"K Sorgjerd","year":"2008","unstructured":"Sorgjerd K, Klingstedt T, Lindgren M, Kagedal K, Hammarstr\u00f6m P (2008) Prefibrillar transthyretin oligomers and cold stored native tetrameric transthyretin are cytotoxic in cell culture. Biochem Biophys Res Commun 377:1072\u20131078","journal-title":"Biochem Biophys Res Commun"},{"key":"13_CR98_13","doi-asserted-by":"crossref","first-page":"14420","DOI":"10.1074\/jbc.M010869200","volume":"276","author":"MM Sousa","year":"2001","unstructured":"Sousa MM, Saraiva MJ (2001) Internalization of transthyretin. Evidence of a novel yet unidentified receptor-associated protein (RAP)-sensitive receptor. J Biol Chem 276:14420\u201314425","journal-title":"J Biol Chem"},{"key":"13_CR99_13","doi-asserted-by":"publisher","first-page":"38176","DOI":"10.1074\/jbc.M002886200","volume":"275","author":"MM Sousa","year":"2000","unstructured":"Sousa MM, Norden AG, Jacobsen C, Willnow TE, Christensen EI, Thakker RV, Verroust PJ, Moestrup SK, Saraiva MJ (2000) Evidence for the role of megalin in renal uptake of \u00adtransthyretin. J Biol Chem 275:38176\u201338181","journal-title":"J Biol Chem"},{"key":"13_CR100_13","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/S0002-9440(10)63050-7","volume":"159","author":"MM Sousa","year":"2001","unstructured":"Sousa MM, Cardoso I, Fernandes R, Guimar\u00e3es A, Saraiva MJ (2001a) Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates. Am J Pathol 159:1993\u20132000","journal-title":"Am J Pathol"},{"key":"13_CR101_13","doi-asserted-by":"crossref","first-page":"7576","DOI":"10.1523\/JNEUROSCI.21-19-07576.2001","volume":"21","author":"MM Sousa","year":"2001","unstructured":"Sousa MM, Du Yan S, Fernandes R, Guimar\u00e3es A, Stern D, Saraiva MJ (2001b) Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. J Neurosci 21:7576\u20137586","journal-title":"J Neurosci"},{"key":"13_CR102_13","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/S0002-9440(10)64469-0","volume":"161","author":"MM Sousa","year":"2002","unstructured":"Sousa MM, Fernandes R, Palha JA, Taboada A, Vieira P, Saraiva MJ (2002) Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro. Am J Pathol 161:1935\u20131948","journal-title":"Am J Pathol"},{"key":"13_CR103_13","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1046\/j.1471-4159.2003.02309.x","volume":"88","author":"JC Sousa","year":"2004","unstructured":"Sousa JC, Grandela C, Fernandez-Ruiz J, De Miguel R, De Sousa L, Magalhaes AI, Saraiva MJ, Sousa N, Palha JA (2004) Transthyretin is involved in depression-like behaviour and exploratory activity. J Neurochem 88:1052\u20131058","journal-title":"J Neurochem"},{"key":"13_CR104_13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1096\/fj.04-2022fje","volume":"19","author":"MM Sousa","year":"2005","unstructured":"Sousa MM, Do Amaral JB, Guimaraes A, Saraiva MJ (2005) Up-regulation of the extracellular matrix remodeling genes, biglycan, neutrophil gelatinase-associated lipocalin, and matrix metalloproteinase-9 in familial amyloid polyneuropathy. FASEB J 19:124\u2013126","journal-title":"FASEB J"},{"key":"13_CR105_13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.nlm.2007.07.006","volume":"88","author":"JC Sousa","year":"2007","unstructured":"Sousa JC, Marques F, Dias-Ferreira E, Cerqueira JJ, Sousa N, Palha JA (2007) Transthyretin influences spatial reference memory. Neurobiol Learn Mem 88:381\u2013385","journal-title":"Neurobiol Learn Mem"},{"key":"13_CR106_13","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S0006-291X(83)80224-1","volume":"116","author":"S Tawara","year":"1983","unstructured":"Tawara S, Nakazato M, Kangawa K, Matsuo H, Araki S (1983) Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun 116:880\u2013888","journal-title":"Biochem Biophys Res Commun"},{"key":"13_CR107_13","doi-asserted-by":"publisher","first-page":"21998","DOI":"10.1074\/jbc.M602302200","volume":"281","author":"PF Teixeira","year":"2006","unstructured":"Teixeira PF, Cerca F, Santos SD, Saraiva MJ (2006) Endoplasmic reticulum stress associated with extracellular aggregates. Evidence from transthyretin deposition in familial amyloid polyneuropathy. J Biol Chem 281:21998\u201322003","journal-title":"J Biol Chem"},{"key":"13_CR108_13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/labinvest.3780246","volume":"81","author":"MH Teng","year":"2001","unstructured":"Teng MH, Yin JY, Vidal R, Ghiso J, Kumar A, Rabenou R, Shah A, Jacobson DR, Tagoe C, Gallo G, Buxbaum J (2001) Amyloid and nonfibrillar deposits in mice transgenic for wild-type human transthyretin: a possible model for senile systemic amyloidosis. Lab Invest 81:385\u2013396","journal-title":"Lab Invest"},{"key":"13_CR109_13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/j.1460-2075.1993.tb05707.x","volume":"12","author":"CJ Terry","year":"1993","unstructured":"Terry CJ, Damas AM, Oliveira P, Saraiva MJ, Alves IL, Costa PP, Matias PM, Sakaki Y, Blake CC (1993) Structure of Met30 variant of transthyretin and its amyloidogenic implications. EMBO J 12:735\u2013741","journal-title":"EMBO J"},{"key":"13_CR110_13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/j.1460-2075.1993.tb05708.x","volume":"12","author":"C Thyl\u00e9n","year":"1993","unstructured":"Thyl\u00e9n C, Wahlqvist J, Haettner E, Sandgren O, Holmgren G, Lundgren E (1993) Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation. EMBO J 12:743\u2013748","journal-title":"EMBO J"},{"key":"13_CR111_13","volume-title":"Amyloid and amyloidosis 1990","author":"J Wahlquist","year":"1991","unstructured":"Wahlquist J, Thyl\u00e9n C, Haettner E, Snadgren O, Holmgren G, Lundgren E (1991) Structure of transthyretin molecule in amyloid fibrils from the vitreous body in individuals with the Met30 mutation. In: Natvig JB, Forre O, Husby G, Husebekk A, Skogen B, Sletten K, Westermark P (eds) Amyloid and amyloidosis 1990. Kluwer Academic Publishers, Dordrecht"},{"key":"13_CR112_13","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1073\/pnas.87.7.2843","volume":"87","author":"P Westermark","year":"1990","unstructured":"Westermark P, Sletten K, Johansson B, Cornwell GG 3rd (1990) Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 87:2843\u20132845","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR113_13","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/mus.880170611","volume":"17","author":"K Yamamoto","year":"1994","unstructured":"Yamamoto K, Hsu SP, Yoshida K, Ikeda S, Nakazato M, Shiomi K, Cheng SY, Furihata K, Ueno I, Yanagisawa N (1994) Familial amyloid polyneuropathy in Taiwan: identification of transthyretin variant (Leu55 \u2009\u2192 \u2009Pro). Muscle Nerve 17:637\u2013641","journal-title":"Muscle Nerve"},{"key":"13_CR114_13","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1080\/07853890902806576","volume":"41","author":"SF Yan","year":"2009","unstructured":"Yan SF, Yan SD, Ramasamy R, Schmidt AM (2009) Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation. Ann Med 41:408\u2013422","journal-title":"Ann Med"},{"key":"13_CR115_13","first-page":"403","volume":"138","author":"S Yi","year":"1991","unstructured":"Yi S, Takahashi K, Naito M, Tashiro F, Wakasugi S, Maeda S, Shimada K, Yamamura K, Araki S (1991) Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met30) gene. Pathologic similarity to human familial amyloidotic polyneuropathy, type I. Am J Pathol 138:403\u2013412","journal-title":"Am J Pathol"},{"key":"13_CR116_13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0022-2836(02)00028-1","volume":"318","author":"CM Yip","year":"2002","unstructured":"Yip CM, Darabie AA, Mclaurin J (2002) A\u03b242-peptide assembly on lipid bilayers. J Mol Biol 318:97\u2013107","journal-title":"J Mol Biol"},{"key":"13_CR117_13","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1016\/j.bpj.2008.12.3957","volume":"96","author":"T Zako","year":"2009","unstructured":"Zako T, Sakono M, Hashimoto N, Ihara M, Maeda M (2009) Bovine insulin filaments induced by reducing disulfide bonds show a different morphology, secondary structure, and cell toxicity from intact insulin amyloid fibrils. Biophys J 96:3331\u20133340","journal-title":"Biophys J"}],"container-title":["Non-fibrillar Amyloidogenic Protein Assemblies - Common Cytotoxins Underlying Degenerative Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-94-007-2774-8_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T13:23:22Z","timestamp":1713360202000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-94-007-2774-8_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,8]]},"ISBN":["9789400727731","9789400727748"],"references-count":117,"URL":"https:\/\/doi.org\/10.1007\/978-94-007-2774-8_13","relation":{},"subject":[],"published":{"date-parts":[[2011,12,8]]},"assertion":[{"value":"8 December 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}